FindTrial
Sign In

Based on spectrum to detect ctDNA and its application on the CRC diagnosis and prognosis

Based on spectrum to detect ctDNA and its application on the CRC diagnosis and prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006289
Enrollment
Unknown
Registered
2015-04-19
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Gold Standard:
Index test:

Sponsors

Institution of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: CRC patients, patients with colorectal polyps, healthy people

Exclusion criteria

Exclusion criteria: Non-CRC patients, patients without colorectal polyps, Non-healthy people

Design outcomes

Primary

MeasureTime frame
gene mutation;—

Countries

China

Contacts

Public ContactLing Chen
chendoc@126.com+86 13875885271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026